CLINICAL_TRIALS
trial_result
· 2022-09-06
Clinical Trial Update: Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy [Phase 4]
Summary
A Phase 4 clinical trial update assessing disturbance of plasma cytokine parameters in clozapine-resistant, treatment-refractory schizophrenia and their associa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED